Spero Therapeutics
SPRO
#9398
Rank
NZ$92.09 M
Marketcap
$1.69
Share price
-4.30%
Change (1 day)
-21.23%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2024 (TTM): -NZ$2.45 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are NZ$89.86 Million. In 2023 the company made an earning of NZ$49.22 Million, an increase over its 2022 earnings that were of -NZ$77.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$2.45 Million-104.97%
2023 NZ$49.22 M-163.53%
2022 -NZ$77.49 Million-50.14%
2021 -NZ$0.16 Billion11.06%
2020 -NZ$0.14 Billion25.15%
2019 -NZ$0.12 Billion47.68%
2018 -NZ$75.72 Million5.61%
2017 -NZ$71.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$58.44 M-57,075.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.05 B-10,775,962.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.99 B-2,917,341.38%๐Ÿ‡จ๐Ÿ‡ฆ Canada